Cord blood beyond transplantation: can we use the experience to advance all cell therapies?
A Scaradavou - British Journal of Haematology, 2021 - Wiley Online Library
Unrelated cord blood (CB) units, already manufactured, fully tested and stored, are high‐
quality products for haematopoietic stem cell transplantation and cell therapies, as well as …
quality products for haematopoietic stem cell transplantation and cell therapies, as well as …
Neural Network-Based Filter Design for Compressive Raman Classification of Cells
S Semrau - Journal of Chemical Information and Modeling, 2024 - ACS Publications
Cell-based therapies are bound to revolutionize medicine, but significant technical hurdles
must be overcome before wider adoption. In particular, nondestructive, label-free methods to …
must be overcome before wider adoption. In particular, nondestructive, label-free methods to …
Optimized reagents for immunopotency assays on mesenchymal stromal cells for clinical use
S Torrents, AE Del Moral, M Codinach… - Immunologic …, 2023 - Springer
Multipotent mesenchymal stromal cells (MSC) offer new therapeutic opportunities based on
their ability to modulate an imbalanced immune system. Immunomodulatory potency is …
their ability to modulate an imbalanced immune system. Immunomodulatory potency is …
Multicenter evaluation of the IL‐3‐pSTAT5 assay to assess the potency of cryopreserved stem cells from cord blood units: The BEST Collaborative study
P Trépanier, D Fournier, C Simard, MJ Fontaine… - …, 2022 - Wiley Online Library
Abstract Background The IL‐3‐pSTAT5 assay, a new, rapid, and standardized flow‐
cytometry‐based assay may compensate for several limitations of the colony‐forming unit …
cytometry‐based assay may compensate for several limitations of the colony‐forming unit …